EFG706 - PRIMARY METABOLITES
Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
---|---|---|---|---|---|---|
PRIMARY METABOLITES | EFG706 | 1st Semester | 2 | 0 | 2 | 7 |
Prequisites | ||||||
Course language | Turkish | |||||
Course type | Elective | |||||
Mode of Delivery | Face-to-Face | |||||
Learning and teaching strategies | Lecture Discussion | |||||
Instructor (s) | Prof. Dr. AyÅŸe UZ, Assist. Prof .Dr. V. Murat KUTLUAY, Assist. Prof .Dr. Zeynep DOGAN | |||||
Course objective | To emphasize the importance of primary metabolites, structures, general propoties, biogenesis of primary metabolites, drugs containing primary metabolites, biological activities of them, highlight of primary metabolites in the field of pharmacognosy | |||||
Learning outcomes |
| |||||
Course Content | Chemistry of sugars, fats and proteins; place, importance and medicinal properties of primary metabolites in pharmacognosy and properties, importance and activities of important primary metabolite-containing medicinal plants | |||||
References | 1. Dewick PM, Medicinal Natural Products, John Wiley&Sons LTD, 2. Edition, West Sussex, 2002. 2. Trease and Evans Pharmacognosy, Saunders Elsevier, 16. Edition, Philadelphia, 2009. 3. Notes of lecture |
Course outline weekly
Weeks | Topics |
---|---|
Week 1 | Introduction, monosaccharides, oligosaccharides (disaccharides, disaccharide derivatives, oligosaccharides) : Definitions, Biogenesis, General properties |
Week 2 | Polysaccharides (fructans, galactans, uronic acid derivatives, musilages, aminosugars) |
Week 3 | Plants and drugs used for industrial source of carbohydrates and carbohydrate derivatives |
Week 4 | Polysaccharides (musilages,musilages containing drugs, aminosugars) |
Week 5 | Polysaccharides (musilages,musilages containing drugs, aminosugars) |
Week 6 | Fruit acids, faty acids and esters (structures, general properties, quality control of them) |
Week 7 | Oils obtained from natural sources (saturated, unsaturated oils) |
Week 8 | Waxs, phospolipids |
Week 9 | Other lipids (aliphatic alcohols, esthers, alkenes, alkynes, acetogenins) |
Week 10 | Other compounds in the lipid group (aliphatic alcohols, esters, alkenes, alkynes, acetogenins) |
Week 11 | Amino acids, peptids, proteins, ((structures, classifications, general properties) |
Week 12 | Compounds has proteinic structues, hormones |
Week 13 | Lectins and enzymes |
Week 14 | Enzyme inhibitors, and enzyme drugs |
Week 15 | Preparation for presentation |
Week 16 | PRESENTATION |
Assesment methods
Course activities | Number | Percentage |
---|---|---|
Attendance | 30 | 0 |
Laboratory | 0 | 0 |
Application | 0 | 0 |
Field activities | 0 | 0 |
Specific practical training | 0 | 0 |
Assignments | 1 | 50 |
Presentation | 1 | 50 |
Project | 0 | 0 |
Seminar | 0 | 0 |
Midterms | 0 | 0 |
Final exam | 0 | 0 |
Total | 100 | |
Percentage of semester activities contributing grade succes | 0 | 50 |
Percentage of final exam contributing grade succes | 0 | 50 |
Total | 100 |
WORKLOAD AND ECTS CALCULATION
Activities | Number | Duration (hour) | Total Work Load |
---|---|---|---|
Course Duration (x14) | 14 | 2 | 28 |
Laboratory | 0 | 0 | 0 |
Application | 0 | 0 | 0 |
Specific practical training | 0 | 0 | 0 |
Field activities | 0 | 0 | 0 |
Study Hours Out of Class (Preliminary work, reinforcement, ect) | 14 | 5 | 70 |
Presentation / Seminar Preparation | 1 | 30 | 30 |
Project | 0 | 0 | 0 |
Homework assignment | 1 | 40 | 40 |
Midterms (Study duration) | 0 | 0 | 0 |
Final Exam (Study duration) | 1 | 42 | 42 |
Total Workload | 31 | 119 | 210 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
D.9. Key Learning Outcomes | Contrubition level* | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
1. Able to identify, analyze, and assess biological effects of natural-sourced drugs and materials. | X | ||||
2. Able to access current scientific Pharmacognosy information proficiently. | X | ||||
3. Able to master the biosynthetic pathways, chemical structures, classification, chemical and biological properties, diagnosis, and quantification of primary and secondary metabolism products in natural resources. | X | ||||
4. Able to perform and interpret various analyses on natural compounds. | X | ||||
5. Able to extract, purify, and characterize new or known compounds. | X | ||||
6. Able to assess biological effects of natural extracts and compounds. | X | ||||
7. Able to access natural resources responsibly, with environmental awareness | X | ||||
8. Able to advise health institutions and patients on public health matters. | X | ||||
9. Able to conduct ethical pharmacognostical studies, adhering to laws. | X | ||||
10. Able to utilize and evaluate information from reference sources effectively. | X | ||||
11. Able to inform the public about natural products through media. | X | ||||
12. Able to develop healthcare quality improvement policies addressing health issues. | X | ||||
13. Able to utilize natural product knowledge to enhance societal health. | X | ||||
14. Able to integrate pharmacognosy with other disciplines to propose solutions. | X | ||||
15. Able to provide scientific consultancy on natural products to relevant industries. | X |
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest